YOU'RE PREGNANT. We'll help you avoid complications. You'll give birth to a healthy baby.

YOU’RE PREGNANT. HOORAY!

We’ll help you avoid complications.

You’ll give birth to a healthy baby

and maintain your health

for years to come…

The most common and serious complication of pregnancy is preeclampsia (PE). According to the World Health Organization, PE and other hypertensive disorders of pregnancy occur in approximately 2-8% of pregnancies and are among the leading causes of maternal mortality and severe maternal morbidity in subsequent decades. PE leads to premature birth, fetal growth restriction, stillbirth, and high neonatal mortality in the first 28 days of life.

Preeclampsia is currently considered an important predictor of future maternal health. Women with a history of PE have an increased risk of developing chronic hypertension, coronary heart disease, chronic heart failure, stroke, chronic kidney disease, as well as type 2 diabetes and metabolic syndrome in subsequent decades. Similarly, an increased risk of arterial hypertension, impaired vascular reactivity, metabolic changes, and neurocognitive impairment has been reported in offspring born with PE. Thus, PE can be considered a possible mechanism for the development of general cardiovascular and metabolic risk throughout the lifespan of both mother and child.

From a practical standpoint, it is crucial to recognize the signs of severe PE as early as possible, as they determine the appropriate treatment strategy, the need for hospitalization in a specialized hospital, and the optimal timing of delivery. At the same time, standard clinical and laboratory criteria do not always adequately determine the risk of PE in a particular patient. This emphasizes the need for a more nuanced, pathogenetically focused, broad approach, including an assessment of laboratory and instrumental (hardware) data, taking into account the mother’s medical history and her demographic characteristics.

This means that the physician must evaluate a vast amount of data, identify the risk of developing PE, and immediately begin prevention and/or treatment of complications in the mother and fetus.

To assist obstetricians and gynecologists, we have created a clinical pregnancy navigator (navigator). The navigator is based on a computer program developed based on clinical recommendations from the Russian Ministry of Health and current international guidelines from ISSHP, ACOG, and NICE regarding PE and other hypertensive disorders of pregnancy.

After testing in Moscow clinics, the navigator will be published on the website